Swiss testing and inspection giant SGS (SIX:SGSN) announced it has ended discussions over a potential $30 billion merger with French competitor Bureau Veritas. In a brief statement, SGS confirmed the talks had concluded without an agreement, declining to provide further details.
Earlier this month, reports suggested the merger could have been an all-stock transaction, potentially involving SGS shares being listed in Paris. This scenario faced potential hurdles due to longstanding restrictions stemming from a Swiss-EU stock market dispute.
In 2019, Switzerland introduced protective measures barring the listing of Swiss shares in the EU after the bloc revoked the Swiss exchange’s equivalence status amidst trade negotiations. While Swiss financial authorities acknowledged such regulatory complexities could impact cross-border deals, it remains unclear if these challenges influenced the decision to terminate the merger talks.
The merger would have combined two major players in the global testing and inspection market, aiming to create a stronger competitive position. However, the end of negotiations leaves both companies continuing independently in a competitive landscape.
SGS declined to comment further on the reasons behind its decision. For now, the possibility of a tie-up between the two industry leaders appears off the table, leaving stakeholders to speculate on what might come next for each company.


Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks
Trump Says Anthropic No Longer Seen as National Security Threat
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched
Saudi Aramco Explores Sulphur Business Stake Sale to Raise Billions
SK Hynix Overtakes Samsung as South Korea’s Most Valuable Company 



